NuEyes
OperatingNuEyes Technologies Inc.
Healthcare · Newport Beach, CA · Founded 2016
Wearable Technology of the Future
Financials
FY2018–FY2019 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inBlue bars are the pre-money valuation the company stated for a priced round.
Share price over rounds
Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.
Fundraising history
Team
5 people
Mark Greget is a U.S. Navy veteran and an accomplished medical technology entrepreneur. Founder of Los Angeles Low Vision which was recognized as a leader in the medical industry and became the number two distribution company in the country responsible for millions in revenue. Mark has a track record of successfully launching innovative products., Poised to launch 3 new products in 2020 including a revolutionary SaaS Surgical suite. Authored patent holding significant value and long-term market exclusivity.
Trevor brings over fifteen years of extensive consulting and business development experience with AR hardware and software applications. Helped position enterprises to accomplish successful AR use cases, KPI's and ultimately large scale deployments. Trevor’s expertise lies heavy in manufacturing, field services, pharma/life sciences, automotive, oil & gas, retail, telecom, AEC, and healthcare.
Attorney Bennett Root brings three decades of experience representing privately owned businesses. His experience goes far beyond the ordinary and is particularly geared towards serving entrepreneurs and startups. He has a B.A. Economics, University of Michigan, 1966 (Honors) and a J.D., Harvard Law School, 1969 (cum laude).
Randy has more than 15 years of project management experience, strong technical background that includes detailed hardware, software, and systems design. Principal inventor on three U.S.Patents. Worked for Boeing, The Walt Disney Company, General Electric, and United Technologies. Randy has extensive experience in Earned Value Management, GE’s Six Sigma process as well as United Technologies’ ACE process where he brought more than 400 new products to market in only 18 months.
Regina Chatman is responsible for high year over year growth, millions of dollars in revenue, and reseller productivity increasing in excess of 400%. Prior to NuEyes, held senior leadership role at assistive technology manufacturer. Achieved high sales growth rates and lead a team directly responsible for 20M+ in annual sales. Assistive technology industry for 11+ years; customer care, distribution communications and support. She studied business administration at Cal State University Long Beach.
Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
Filed 0 of 6 annual reports (FY2020–FY2025)
Missing: 2020, 2021, 2022, 2023, 2024, 2025
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.